Abstract: Provided herein are methods, assays and devices for the detection and diagnosis of autoimmune diseases, including systemic lupus erythematosus. The methods, assays and devices provided herein analyzes binding patterns of peripheral-blood antibodies on peptide array that correlates well with current systemic lupus erythematosus clinical assessment standards.

Abstract: Provided herein are methods, assays and devices for the differential diagnosis and detection of disease progression of autoimmune diseases. The methods, assays and devices provided herein produce and analyze binding patterns of peripheral-blood antibodies on mimetic peptide arrays that differentiate autoimmune diseases, and identify patients progressing to internal organ complications such as interstitial lung disease (ILD), and gastric antral vascular ectasia (GAVE), or renal involvement.

Abstract: A system and method for monitoring electronic gaming machine play to determine outcome patterns indicative of cheating or malfunctioning of the electronic gaming machine. The system and method monitors, in substantially real time, an accounting system database associated with the subject electronic gaming machine and compares Par sheet data and theoretical outcomes for the subject gaming machine. In the event cheating is taking place or a malfunction has occurred, the system and method is configured to recognize the same, lock up the electronic gaming machine and/or notify casino personnel.

Abstract: The disclosed embodiments concern methods, devices, and systems for identifying candidate biomarkers useful for the diagnosis, prognosis, monitoring and screening and/or as targets for the treatment of diseases and conditions in subjects, in particular autoimmune and infectious diseases. The identification of candidate biomarkers is predicated on identifying discriminating peptides present on a peptide array, which can distinguish samples from different subjects having different health conditions by the binding patterns of antibodies present in the samples.

Abstract: Provided herein are methods, assays and devices for the differential diagnosis and detection of disease progression of autoimmune diseases. The methods, assays and devices provided herein produce and analyze binding patterns of peripheral-blood antibodies on mimetic peptide arrays that differentiate autoimmune diseases, and identify patients progressing to internal organ complications such as interstitial lung disease (ILD), and gastric antral vascular ectasia (GAVE), or renal involvement.

Abstract: The disclosed embodiments concern methods, devices, and systems for identifying candidate biomarkers useful for the diagnosis, prognosis, monitoring and screening and/or as targets for the treatment of diseases and conditions in subjects, in particular autoimmune and infectious diseases. The identification of candidate biomarkers is predicated on identifying discriminating peptides present on a peptide array, which can distinguish samples from different subjects having different health conditions by the binding patterns of antibodies present in the samples.

Abstract: The disclosed embodiments concern methods, apparatus, and systems for providing differential diagnosis of autoimmune diseases including, Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA). The disclosed embodiments provide for differentially diagnosing autoimmune diseases from each other, from other autoimmune diseases, and from mimic disease conditions that are not classified as autoimmune, but that present with symptoms that are often associated with the autoimmune diseases.

Abstract: The disclosed embodiments concern non-invasive methods, and apparatus, and systems for identifying infections. The methods are predicated on identifying discriminating peptides present on a peptide array, which are differentially bound by the different mixtures of antibodies present in samples from subjects consequent to an infection relative to binding of mixtures of antibodies present in reference subjects.

Abstract: Provided herein are methods, assays and devices for the detection and diagnosis of autoimmune diseases, including systemic lupus erythematosus. The methods, assays and devices provided herein analyzes binding patterns of peripheral-blood antibodies on peptide array that correlates well with current systemic lupus erythematosus clinical assessment standards.

Abstract: Examples disclosed herein relate to systems and methods where one or more electronic gaming devices each include a memory with one or more modules and a processor which may generate one or more symbols to be located in the one or more areas on a plurality of reels. The processor may initiate one or more game play functions and each electronic gaming device may include a license. Further, a license server may verify one or more licenses on the one or more electronic gaming devices where a verification status is determined based on a license being in an active state.

Abstract: Examples disclosed herein relate to systems and methods for utilizing one or more presentations and one or more ambient light shows. The electronic gaming device may include a plurality of reels. The plurality of reels may include one or more areas. The electronic gaming device may include a memory and one or more processors. The memory may include one or more ambient lighting modules, one or more presentation modules, and/or one or more synchronization modules. The electronic gaming device may include one or more ambient light sensors and/or one or more light emitters. Further, the one or more processors may display one or more presentations and initiate one or more ambient light shows.

Abstract: Examples disclosed herein relate to systems and methods for utilizing one or more universal player tracking systems. The electronic gaming device may include a memory, a processor, and a plurality of reels. The plurality of reels may include one or more areas. The memory may include a universal player tracking module. The processor may generate one or more symbols to be located in the one or more areas and to validate one or more universal player tracking numbers based on data received from an external device.

Abstract: Examples disclosed herein relate to systems and methods, which may receive wagers on one or more paylines. The systems and methods may utilize one or more tournament game structures. The systems and methods may utilize one or more power-up cards in the one or more tournament game structures.

Abstract: Examples disclosed herein relate to systems and methods, which may receive wagers on one or more paylines. The systems and methods may utilize one or more tournament game structures. The systems and methods may utilize one or more power-up cards in the one or more tournament game structures.

Abstract: Examples disclosed herein relate to systems and methods for delivering game play, which may include providing wagering game options that may include a two-dimensional option, a three-dimensional option, and/or a combination of both.